Design and In Vivo Anti‐Inflammatory Effect of Ketoprofen Delayed Delivery Systems. Issue 10 (18th June 2015)

• Record Type: Journal Article
• Authors: Cerciello, Andrea; Auriemma, Giulia; Morello, Silvana; Pinto, Aldo; Del Gaudio, Pasquale; Russo, Paola; Aquino, Rita P.
• Is Part Of: Journal of pharmaceutical sciences. Volume 104:Issue 10(2015:Oct.)
• Page Start: 3451
• Page End: 3458
• Publication Date: 2015-06-18
• Subjects: Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.24554
• Languages: English
• ISSNs: 0022-3549

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>For the treatment of inflammatory‐based diseases affected by circadian rhythms, the development of once‐daily dosage forms is required to target early morning symptoms. In this study, Zn–alginate beads containing ketoprofen (K) were developed by a tandem technique prilling/ionotropic gelation. The effect of main critical variables on particles micromeritics, inner structure as well as on drug loading and <italic>in vitro</italic> drug release was studied. The <italic>in vivo</italic> anti‐inflammatory efficacy was evaluated using a modified protocol of carrageenan‐induced edema in rat paw administering beads to rats by oral gavage at 0, 3, or 5 h before edema induction. Good drug loading and desired particle size and morphology were obtained for the optimized formulation F20. <italic>In vitro</italic> dissolution studies showed that F20 had a gastroresistant behavior and delayed release of the drug in simulated intestinal fluid. The <italic>in vitro</italic> delayed release pattern was clearly reflected in the prolonged anti‐inflammatory effect <italic>in vivo</italic> of F20, compared to pure ketoprofen; F20, administered 3 h before edema induction, showed a significant anti‐inflammatory activity, reducing maximum paw volume in response to carrageenan injection, whereas no response was observed for ketoprofen. The designed beads appear a promising platform suitable for a delayed release of anti‐inflammatory drugs. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:3451–3458, 2015</p> </abstract>